Shionogi Completes ¥6 Billion Tablet Production Facility
This article was originally published in PharmAsia News
Executive Summary
Shionogi completed Nov. 11 the construction of a tablet manufacturing and packaging facility in Settsu, Osaka. With an investment of ¥6 billion, the new facility is built according to current good manufacturing practices required by U.S. FDA. The facility has a capacity of producing 550 million clinic trial and commercial drug tablets and one billion capsules each year. (Click here for more - Japanese language